PMEF
ANGO icon

Point72 Middle East FZE’s AngioDynamics ANGO Stock Holding History

Point72 Middle East FZE’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,683
Closed -$13.2K – 99
2023
Q4 		$13.2K Buy
+1,683
New +$11.7K ﹤0.01% 1386
2023
Q2 		– Sell
-3,987
Closed -$41.2K – 1525
2023
Q1 		$41.2K Buy
3,987
+2,351
+144% +$30.1K ﹤0.01% 1300
2022
Q4 		$22.5K Buy
+1,636
New +$22.8K ﹤0.01% 1610

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Point72 Middle East FZE's ANGO Position: Q1 2024 in Review

Point72 Middle East FZE sold out of AngioDynamics (ANGO) in Q1 2024, closing a stake of 1,683 shares — an estimated $13.2K sold.

Point72 Middle East FZE first reported a position in ANGO in Q4 2022 and held it in 3 quarters. The position peaked at $41.2K in Q1 2023. 135 funds tracked by Wall St. Rank hold ANGO as of Q1 2024.

  • Point72 Middle East FZE reported no remaining AngioDynamics position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 1,683 AngioDynamics shares in Q1 2024, an estimated $13.2K.
  • Point72 Middle East FZE first reported a position in AngioDynamics in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's AngioDynamics position peaked at $41.2K in Q1 2023.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.